StockNews.com Initiates Coverage on IRIDEX (NASDAQ:IRIX)

StockNews.com assumed coverage on shares of IRIDEX (NASDAQ:IRIX) in a report issued on Friday. The firm issued a hold rating on the medical equipment provider’s stock.

IRIDEX Stock Performance

IRIX stock opened at $1.51 on Friday. The business’s 50-day moving average price is $1.65 and its two-hundred day moving average price is $1.72. The company has a current ratio of 1.54, a quick ratio of 0.85 and a debt-to-equity ratio of 0.55. The firm has a market cap of $25.04 million, a PE ratio of -2.25 and a beta of 0.84. IRIDEX has a 1-year low of $1.27 and a 1-year high of $3.65.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.